GDP Guidance

Finalist for Northamptonshire Innovative Business of the Year Award

Celebrating the Sponsors Supporting the UK GDP Annual Conference 2026

As a Community Interest Company (CIC), the UK GDP Association exists to serve the GxP community rather than generate profits for shareholders. Our mission is to support the pharmaceutical sector by promoting best practice, facilitating professional development and encouraging collaboration to improve GxP standards across the industry. To achieve this, we rely on the support of organisations that share our vision and commitment to patient safety, product quality and continuous improvement.

Why Attend the 2026 Conference

One of the biggest benefits of attending the UK GDP Annual Conference 2026 is the opportunity to hear directly from industry experts, regulators and experienced practitioners on the topics that are shaping the future of pharmaceutical manufacturing and distribution. The conference programme has been carefully designed to address both current challenges and emerging trends across GxP, quality, operations and regulatory compliance, bringing together an exceptional line-up of speakers.

Stronger Together: Why Networking Matters in the GxP Community

Good practice in the pharmaceutical industry is about far more than regulations, procedures, and inspections. At its heart lies a shared commitment to ensuring that patients receive safe, effective medicines that have been manufactured, stored, transported, and distributed to the highest possible standards.

Unlocking the Full Value of Your UK GDP Association Membership

Designed specifically for professionals working within pharmaceutical manufacture and distribution, GxP compliance and quality management, this secure area provides practical tools, valuable resources and networking opportunities that support members throughout the year.

Welcome to the New and Improved UK GDP Association Website

We are delighted to welcome you to the newly redesigned UK GDP Association website. Our new online home has been created to make it easier than ever for pharmaceutical manufacturers, wholesalers, pharmacies, dispensing doctors, cash and carry’s, transport providers and any other organisations involved in the manufacture and distribution of medicines.

Understanding Key GDP Roles with Alan Bentley & Haseena Mooncey

Delegates praise Alan and Haseena for delivering a balanced, honest, and deeply practical session. Their combined expertise helped clarify complex GDP roles and shed light on the importance of competency, documentation, separation of duties, and the human element behind regulatory compliance. As many attendees commented, the session was a valuable reminder that GDP success starts with the right people, in the right roles, with the right support.

The Licence Holder and the Law: Insights from Ben Thorogood

Among the most eye-opening sessions at the 2025 UK GDP Association Annual Conference was The Licence Holder and the Law, delivered by legal expert Ben Thorogood. In a sector where compliance failures can escalate rapidly into legal and financial crises, Ben’s session served as a critical reminder of the legal obligations that underpin every Wholesale Distribution Authorisation (WDA), Quality Technical Agreement (QTA), and GDP-governed process.

Navigating Regulations for Medical Devices and Diagnostics

Johanne stressed the importance of these two regulations in protecting public health by ensuring that medical device and IVDs are safe and effective for consumer and clinical use. The regulations ensure that medical devices and diagnostics meet high quality standards and benefit both healthcare providers and patients. She added that the MDR and IVDR aim to enhance the competitiveness of the EU market, whilst ensuring that innovation is encouraged amongst manufacturers.

When It All Goes Wrong

Good GDP is not built on documents alone, but on people, culture and continuous oversight. Insights shared by Dave in his session reinforced the importance of proactive governance and genuine quality ownership at every level of the organisation. With the knowledge and tools provided by Dave, attendees leave the conference better equipped to handling inspection outcomes and remediation.

An Introduction to Pharmacovigilance

An Introduction to Pharmacovigilance In an informative and engaging virtual session, Joyce Bols kindly pre-recorded a comprehensive overview of pharmacovigilance (PV) and its central role in patient safety to the delegates of our 2025 Annual...

CAPAs and Complaints

Nim Pancholi’s dynamic session on complaints and CAPAs reminded the audience that quality is not just a system, it is a behaviour, a mindset, and a culture. Known throughout the industry for her engaging training style and deep expertise in people development, Nim brought a refreshing, human-centred perspective to a topic hat is often discusses strictly through the lens of compliance.